Enteral Stents - Market Insights, Competitive Landscape and Market Forecast - 2030

Enteral Stents Market By Stent Type (Esophageal Stents, Gastroduodenal Stents, And Colon Stents), Product Type (Fully Covered Enteral Stents, Non-Covered Enteral Stents, And Partially Covered Enteral Stents), End-User (Hospitals, Specialty Clinics, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of gastrointestinal disorders and growing preference for minimally invasive surgeries
The global enteral stents market was estimated to grow at a CAGR of 5.13% during the forecast period from 2024 to 2030. The demand for enteral stents is primarily being boosted by the increasing patient population suffering from various gastrointestinal malignancies like colon cancer, esophageal cancer, and others, the growing preference for minimally-invasive surgeries, continuous innovation in product development among others, thereby contributing to the overall growth of the enteral stents market during the forecast period from 2024-2030.

Enteral Stents Market Dynamics:

According to Global Cancer Observatory 2020 data, globally there were around 604 thousand new cases of esophagus cancer in 2020. As per the same source, there will be around 957 thousand new cases of esophagus cancer by 2040 across the world.

The fact mentioned by the World Cancer Research Fund International states that esophageal cancer is the eighth most common cancer worldwide. In men, it is the seventh most common cancer and the thirteenth most common cancer in women.

As per the World Health Organization 2023, colorectal cancer is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases, and is the second leading cause of cancer-related deaths worldwide. Also, there were nearly 1.15 million new cases of colon cancer registered across the world in 2020, as per the Global Cancer Observatory 2020 data. The source also estimated that there will be around 1.92 million new cases of colon cancer in 2040 globally.

The rise in risk factors such as sedentary lifestyle, obesity, smoking, and excessive alcohol consumption among others associated with various cancers including colon, esophageal, stomach, and others is further going to accelerate the market for enteral stents. The WHO 2023 even mentioned that old age, family history, personal history, unhealthy lifestyle choices, sedentary behavior, obesity, smoking, and excessive alcohol consumption as the major risk factors for colorectal cancer. Globally, in 2020, 22.3% of the world's population used tobacco which included 36.7% of men and 7.8% of women as mentioned by the WHO in 2023.

However, the adverse events and other complications associated with the usage of enteral stents may restrict the growth of the overall enteral stents market.

Enteral Stents Market Segment Analysis:

Enteral Stents Market By Stent Type (Esophageal Stents, Gastroduodenal Stents, and Colon Stents), Product Type (Fully Covered Enteral Stents, Non-Covered Enteral Stents, and Partially Covered Enteral Stents), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the stent type segment of the enteral stents market, the esophageal stents category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with esophageal stents.

Esophageal stents can be utilized for either benign or malignant reasons in the esophagus, gastroesophageal junction, and gastric cardia. The earliest indication for esophageal stent placement was dysphagia secondary to esophageal cancer.

The usage of esophageal stents has increased in recent years and has expanded to cover benign esophageal strictures (peptic, etc.), postoperative radiation (induced, anastomotic, and caustic), external compression from leaks, iatrogenic perforations, extraesophageal tumors, and tracheoesophageal fistulas among others.

For example, WallFlex Esophageal Stents by Boston Scientific Corporation provides luminal patency in patients with esophageal strictures caused by intrinsic or extrinsic malignant tumors by combining flexibility and control for optimal patient care.

Given that the vast majority of esophageal cancer patients present with incurable illnesses, palliation of inoperable malignant blockage remains the most prevalent rationale for esophageal stent insertion.

The minimally invasive strategy of esophageal stenting has enhanced the quality of life of these individuals, who would otherwise have to undergo a potentially morbid surgical surgery or have restricted therapy alternatives.

Therefore, owing to the above-mentioned factors, the esophageal stents category is expected to register significant growth, thereby driving the growth of the overall enteral stents market during the forecast period.

North America is expected to dominate the overall Enteral Stents Market:

Among all the regions, North America is estimated to account for the largest share of the enteral stents market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of colon, stomach, esophageal, and other gastrointestinal cancers, surge in number of smokers and other risk factors responsible for various cancers, high disposable income, supporting government programs and initiatives, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others, the market for enteral stents is expected to witness prosperity in the region during the forecast period 2024-2030.

As per American Cancer Society 2023 data, it was estimated about 64,050 people will be diagnosed with pancreatic cancer in 2023 in the United States. The data included 33,130 cases of men and 30,920 cases of women. As per the same source, pancreatic cancer accounts for about 3% of all cancers in the US.

The above-mentioned source also published about colorectal cancer stating that colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. About 106,970 new cases of colon cancer and 46,050 new cases of rectal cancer were the American Cancer Society's estimates for the number of colorectal cancers in the United States for 2023.

The Colorectal Cancer Control Program (CRCCP) by the Centers for Disease Control and Prevention (CDC) works with clinics, hospitals, and other healthcare organizations to implement and strengthen evidence-based screening. The program aims to increase screening to save lives. Such programs and initiatives in the country would enable more people to be diagnosed and get appropriate treatment including the placement of enteral stents for disease cure and management.

Thus, the above-mentioned factors are likely to propel the growth of the enteral stents market in the region during the forecast period from 2024-2030.

Enteral Stents Market Key Players:

Some of the key market players operating in the Enteral Stents market include Boston Scientific Corporation, Cook Medical, Merit Medical Systems, Micro-Tech (Nanjing) Co., Ltd., Changzhou Health Microport Medical Device Co., LTD., Medi-Globe GmbH, ELLA - CS, s.r.o., Olympus Corporation, M.I.TECH, Medorah Meditek Pvt. Ltd., Advin Health Care, and others.

Recent Developmental Activities in the Enteral Stents Market:

• In October 2020, Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the commercial launch of HANAROSTENT® Esophagus TTS self-expanding metal stents (SEMS) made by M.I. Tech and distributed exclusively through Olympus in the US.

Key Takeaways from the Enteral Stents Market Report Study

• Market size analysis for current enteral stents market size (2023), and market forecast for 6 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global enteral stents market.
• Various opportunities available for the other competitors in the enteral stents market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current enteral stents market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for enteral stents market growth in the coming future?

Target Audience who can be benefited from this Enteral Stents Market Report Study

• Enteral Stents product providers
• Research organizations and consulting companies
• Enteral Stents-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in enteral stents
• Various End-users who want to know more about the enteral stents market and the latest technological developments in the enteral stents market.

Frequently Asked Questions for the Enteral Stents Market:

1. What is meant by enteral stents?

Enteral stents are devices that are used to keep or repair gut luminal patency. If growth in the esophagus, stomach, small intestine, or colon causes an obstruction, they are inserted into the digestive tract.

2. What is the market for global enteral stents?

The global enteral stents market was estimated to grow at a CAGR of 5.13% during the forecast period from 2024 to 2030.

3. What are the drivers for the global enteral stents market?

The demand for enteral stents is primarily being boosted by the increasing patient population suffering from various gastrointestinal malignancies including colon cancer, pancreatic cancer, oesophageal cancer, and others, the surge in the number of risk factors such as smoking, sedentary lifestyle, high levels of alcohol consumption, and others associated with causing various cancers, growing preference for minimally-invasive surgeries, and continuous innovation in endoscopic techniques and enteral stents among others, thereby contributing to the overall growth of the enteral stents market during the forecast period from 2024-2030.

4. Who are the key players operating in the global enteral stents market?

Some of the key market players operating in the enteral stents market include Boston Scientific Corporation, Cook Medical, Merit Medical Systems, Micro-Tech (Nanjing) Co., Ltd., Changzhou Health Microport Medical Device Co., LTD., Medi-Globe GmbH, ELLA - CS, s.r.o., Olympus Corporation, M.I.TECH, MITRA, Advin Health Care, and others.

5. Which region has the highest share in the enteral stents market?

North America is expected to dominate the overall enteral stents market during the forecast period from 2024-2030. Owing to factors such as the rising prevalence of colon, pancreatic, oesophageal, and other gastrointestinal malignancies, the surge in the number of smokers, high disposable income, sophisticated healthcare infrastructure, supporting government programs and initiatives for cancer, and high awareness among others, North American enteral stents market is expected to growth in coming years.


This product will be delivered within 3-5 business days.